DOCSLIB.ORG

A Rapid Ceramide Synthase Activity Using NBD- Sphinganine and Solid Phase Extraction

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
A Rapid Ceramide Synthase Activity Using NBD- Sphinganine and Solid Phase Extraction methods A rapid ceramide synthase activity using NBD- sphinganine and solid phase extraction † † 1, Rotem Tidhar , * Kacee Sims , Eden Rosenfeld-Gur , * Walter Shaw , and Anthony H. Futerman * Department of Biological Chemistry,* Weizmann Institute of Science , Rehovot 76100, Israel ; and Avanti Polar Lipids Inc. , † Alabaster, AL 35007-9105 Abstract Ceramides are synthesized by six mammalian ce- For many years, CerS activity was assayed using radioac- ramide synthases (CerSs), each of which uses fatty acyl- tive substrates [either 3 H-Sph ( 7 ) or 14 C-labeled acyl-CoAs CoAs of different chain lengths for N -acylation of the ( 20 )], with separation of the substrate and products per- sphingoid long-chain base. We now describe a rapid and reli- formed by TLC. Recently, a fl uorescent Sph analog has able CerS assay that uses a fl uorescent N-[6-[(7-nitrobenzo- become available, ␻ (7-nitro-2-1,3-benzoxadiazol-4-yl) 2-oxa-1,3-diazol-4-yl) (NBD ) sphinganine substrate followed by separation of the NBD-lipid substrate and products (2 S ,3 R )-2-aminooctadecane-1,3-diol (NBD-Sph), which is using solid phase extraction (SPE) C18 chromatography. a substrate for CerS ( 18, 21 ). Clearly, the use of fl uores- SPE chromatography is a quick and reliable alternative cent substrates is preferable to use of radioactive substrates to TLC, and moreover, there is no degradation of either as it avoids radiation hazards ( 21 ). NBD-sphinganine or NBD-ceramide. We have optimized the We now describe an assay using NBD-Sph, in which the assay for use with minimal amounts of protein in a minimal fl uorescent lipid products are separated by solid phase ex- volume. This assay will prove useful for the analysis of traction (SPE) C18 chromatography using a 96-well plate. CerS activity, which is of particular importance in light of This assay has a number of advantages over other assays, the growing involvement of CerS in cell regulation and in the pathology of human diseases. —Tidhar, R., K. Sims, E. including short assay times, the use of small reaction vol- Rosenfeld-Gur, W. Shaw, and A. H. Futerman. A rapid umes (20 µl) and small amounts of protein. It alleviates ceramide synthase activity using NBD-sphinganine and solid the use of TLC for lipid separation, which often results in phase extraction. J. Lipid Res . 2015. 56: 193–199. degradation of Sph on the TLC plate. We suggest that this assay will permit the rapid assay of CerS activity in large Supplementary key words c eramides • sphingolipids • in vitro assay • numbers of samples and will prove particularly useful for chromatography • enzymology • long-chain base • fatty acyl-CoA • laboratories that do not have access to facilities available in N -acylation more lipid-oriented laboratories. Ceramide, the backbone of all sphingolipids ( 1 ), is synthesized by the N -acylation of sphingoid long-chain MATERIALS AND METHODS bases by ceramide synthases (CerSs). Mammals contain six distinct CerSs, with each using a subset of fatty acyl- Materials CoAs for the N -acylation of sphinganine (Sph) to gener- Methanol gradient grade for liquid chromatography, water ate dihydroceramides or of sphingosine to generate for chromatography, and silica gel 60 TLC plates were from ceramides ( 2, 3 ). CerSs have become the focus of great Merck (Darmstadt, Germany). Formic acid (purity >98%) was interest due to the realization that ceramides with differ- from Sigma-Aldrich (St. Louis, MO). Chloroform for spectro- ent acyl chain lengths play distinct roles in cell physiol- photometry was from J. T. Baker (Center Valley, PA). Ammo- ogy ( 4–6 ), with studies focusing on biochemical analysis nium acetate was from Macron Chemicals (Center Valley, PA). Strata end-capped silica-based C18-E (15 mg/well) 96-well of the mode of CerS regulation (7–13 ), on biological ap- plates and the vacuum manifold for SPE with vacuum gauge proaches using CerS-null mice ( 4, 6, 14 ), and on patho- and cover mat were from Phenomenex (Torrance, CA). The physiological studies using tissues from patients in which vacuum pump was an Alcatel 2002 from Ideal Vacuum Products CerS activity changes during the development and pro- (Albuquerque, NM). gression of pathology ( 15–19 ). Abbreviations: CerS, ceramide synthase; NBD-C18-ceramide, A. H. Futerman is the Joseph Meyerhoff Professor of Biochemistry at the Weizmann ␻ Institute of Science . (7-nitro-2-1,3-benzoxadiazol-4-yl)- N -stearoyl- D - erythro -sphingosine; NBD-sphinganine, ␻ (7-nitro-2-1,3-benzoxadiazol-4-yl)(2 S ,3 R )-2- Manuscript received 15 June 2014 and in revised form 3 November 2014. aminooctadecane-1,3-diol; Sph, sphinganine; SPE, solid phase extraction . 1 Published, JLR Papers in Press, November 3, 2014 To whom correspondence should be addressed. DOI 10.1194/jlr.D052001 e-mail: [email protected] Copyright © 2015 by the American Society for Biochemistry and Molecular Biology, Inc. This article is available online at http://www.jlr.org Journal of Lipid Research Volume 56, 2015 193 Cell culture, transfection, and preparation of cell homogenates HEK 293T cells were cultured in Dulbecco’s modifi ed Eagle’s medium supplemented with 10% fetal calf serum, 100 IU/ml penicillin, 100 µg/ml streptomycin, and 110 µg /ml sodium py- ruvate. Transfection was performed with the polyethylenimine reagent (Sigma-Aldrich) using 10 µg of plasmid per 10 cm cul- ture dish. Thirty-six to 48 h after transfection, cells were removed from culture dishes and washed twice with phosphate-buffered saline. Cell homogenates were prepared in 20 mM HEPES-KOH, pH 7.2, 25 mM KCl, 250 mM sucrose, and 2 mM MgCl 2 contain- ing a protease inhibitor cocktail (Sigma-Aldrich). Protein was determined using the Bradford reagent (Bio-Rad, Hercules, CA). CerS assay and lipid separation by TLC Cell homogenates were incubated at 37°C with 15 µM NBD- Sph, 20 µM defatted BSA, and 50 µM acyl-CoA, based on condi- tions used previously with [4,5- 3 H]Sph as substrate ( 22 ), but using a 20 ␮ l reaction volume. Reactions were terminated by the addition of chloroform-methanol (1:2, v/v), and lipids were ex- tracted ( 23 ). Lipids were then dried under N2 , resuspended in chloroform-methanol (9:1, v/v), and separated by TLC using chloroform-methanol-2M NH4OH (40:10:1, v/v/v) as the devel- oping solvent. NBD-labeled lipids were visualized using a Typhoon 9410 variable mode imager and quantifi ed by ImageQuantTL (GE Healthcare, Chalfont St. Giles, UK). NBD-Sph stability NBD-Sph (400 µl from a stock solution of 3.7 mg/ml) was separated by preparative TLC using chloroform-methanol-water (65:25:4, v/v/v) as the developing solvent. Bands were excised from the TLC plate and extracted twice using methanol-chloroform (75:25, v/v). NBD-lipids were analyzed using negative ion mode electrospray tandem mass spectrometry with an ABI 4000 QTrap mass spectrometer and an Agilent 1100 series HPLC. A Fig. 1. Structure of NBD-lipids and optimization of CerS assay 5 µl injection volume and a mobile phase consisting of methanol using NBD-Sph. A: Structure of NBD-lipids. B: Homogenates from containing 1% formic acid were used for the analysis. NBD-Sph cells overexpressing CerS5 or CerS4 were assayed in a 20 ␮ l reaction and ␻ (7-nitro-2-1,3-benzoxadiazol-4-yl)-N -stearoyl- D - erythro - volume with increasing amounts of NBD-Sph with 50 ␮ M C16-CoA sphingosine (NBD-C18-ceramide) were also analyzed before and or C20-CoA, respectively, and 20 ␮ M defatted BSA, at 37°C. Results after elution from the SPE columns. are means ± SEM of two to three independent experiments. for CerS4. Both these results compare favorably with Km 3 RESULTS AND DISCUSSION values obtained previously using [4,5- H]Sph ( 22 ) and NBD-Sph ( 21 ) (which were obtained using higher amounts Optimizing conditions for use of NBD-Sph in of protein and/or longer reaction times). The need for the CerS assay lower amounts of protein could be particularly useful While NBD-Sph ( Fig. 1 ) has been used previously to as- when only small amounts of tissue or cells are available, say CerS ( 17, 18, 21 ), no attempts have been made to mini- such as might be the case when using clinical samples. mize reaction volumes to allow the use of small amounts of Interestingly, whereas NBD-Sph was a good substrate biological material or to improve the mode of separating for CerS, { N -[(7-nitro-2-1,3-benzoxadiazol-4-yl)-methyl] NBD-lipid substrates and products. We have now been amino} palmitoyl coenzyme A (NBD-palmitoyl-CoA) did able to decrease the reaction volume to a minimum of not act as a CerS5 substrate ( Fig. 2A ), nor did it act as a 20 µl, rather than the 100–250 µl used previously with [4,5- competitive inhibitor of CerS5 (data not shown), strength- 3 H]Sph ( 22 ) or with NBD-Sph ( 21 ), permitting the use ening the notion ( 4 ) that CerSs are highly specifi c for the of small amounts of protein for the assay. Thus, we could acyl-CoA donor but less specifi c for the sphingoid long- assay CerS5 activity using as little as 1 µg of protein and chain base. Degradation products of NBD-Sph are readily 5 min reaction time, and CerS4 activity using 10 (Fig. 1B ) apparent upon separation by TLC, which is of concern if or 20 µg (not shown) of protein and 20 min reaction time; low levels of CerS activity are assayed because some of the note that each CerS displays different specifi c activities, degradation products have Rf values similar to that of NBD- necessitating optimization of assay conditions for each ceramide ( Fig.
Load more

Recommended publications
  • Environmental Influences on Endothelial Gene Expression
    ENDOTHELIAL CELL GENE EXPRESSION John Matthew Jeff Herbert Supervisors: Prof. Roy Bicknell and Dr. Victoria Heath PhD thesis University of Birmingham August 2012 University of Birmingham Research Archive e-theses repository This unpublished thesis/dissertation is copyright of the author and/or third parties. The intellectual property rights of the author or third parties in respect of this work are as defined by The Copyright Designs and Patents Act 1988 or as modified by any successor legislation. Any use made of information contained in this thesis/dissertation must be in accordance with that legislation and must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the permission of the copyright holder. ABSTRACT Tumour angiogenesis is a vital process in the pathology of tumour development and metastasis. Targeting markers of tumour endothelium provide a means of targeted destruction of a tumours oxygen and nutrient supply via destruction of tumour vasculature, which in turn ultimately leads to beneficial consequences to patients. Although current anti -angiogenic and vascular targeting strategies help patients, more potently in combination with chemo therapy, there is still a need for more tumour endothelial marker discoveries as current treatments have cardiovascular and other side effects. For the first time, the analyses of in-vivo biotinylation of an embryonic system is performed to obtain putative vascular targets. Also for the first time, deep sequencing is applied to freshly isolated tumour and normal endothelial cells from lung, colon and bladder tissues for the identification of pan-vascular-targets. Integration of the proteomic, deep sequencing, public cDNA libraries and microarrays, delivers 5,892 putative vascular targets to the science community.
    [Show full text]
  • Identification of Potential Key Genes and Pathway Linked with Sporadic Creutzfeldt-Jakob Disease Based on Integrated Bioinformatics Analyses
    medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Identification of potential key genes and pathway linked with sporadic Creutzfeldt-Jakob disease based on integrated bioinformatics analyses Basavaraj Vastrad1, Chanabasayya Vastrad*2 , Iranna Kotturshetti 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. 3. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 562209, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Abstract Sporadic Creutzfeldt-Jakob disease (sCJD) is neurodegenerative disease also called prion disease linked with poor prognosis. The aim of the current study was to illuminate the underlying molecular mechanisms of sCJD. The mRNA microarray dataset GSE124571 was downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were screened.
    [Show full text]
  • Investigation of Adiposity Phenotypes in AA Associated with GALNT10 & Related Pathway Genes
    Investigation of Adiposity Phenotypes in AA Associated With GALNT10 & Related Pathway Genes By Mary E. Stromberg A Dissertation Submitted to the Graduate Faculty of WAKE FOREST UNIVERSITY GRADUATE SCHOOL OF ARTS AND SCIENCES in Partial Fulfillment of the Requirements for the Degree of DOCTOR OF PHILOSOPHY In Molecular Genetics and Genomics December 2018 Winston-Salem, North Carolina Approved by: Donald W. Bowden, Ph.D., Advisor Maggie C.Y. Ng, Ph.D., Advisor Timothy D. Howard, Ph.D., Chair Swapan Das, Ph.D. John P. Parks, Ph.D. Acknowledgements I would first like to thank my mentors, Dr. Bowden and Dr. Ng, for guiding my learning and growth during my years at Wake Forest University School of Medicine. Thank you Dr. Ng for spending so much time ensuring that I learn every detail of every protocol, and supporting me through personal difficulties over the years. Thank you Dr. Bowden for your guidance in making me a better scientist and person. I would like to thank my committee for their patience and the countless meetings we have had in discussing this project. I would like to say thank you to the members of our lab as well as the Parks lab for their support and friendship as well as their contributions to my project. Special thanks to Dean Godwin for his support and understanding. The umbrella program here at WFU has given me the chance to meet some of the best friends I could have wished for. I would like to also thank those who have taught me along the way and helped me to get to this point of my life, with special thanks to the late Dr.
    [Show full text]
  • Altered Mrna Expression Levels of the Major Components of Sphingolipid Metabolism, Ceramide Synthases and Their Clinical Implication in Colorectal Cancer
    ONCOLOGY REPORTS 40: 3489-3500, 2018 Altered mRNA expression levels of the major components of sphingolipid metabolism, ceramide synthases and their clinical implication in colorectal cancer SUNG WON JANG1*, WOO-JAE PARK2*, HYEONJI MIN3, TAEG KYU KWON3,4, SEONG KYU BAEK5, ILSEON HWANG6, SHIN KIM3,4 and JONG-WOOK PARK3,4 1Department of Emergency Medicine, Dongsan Medical Center, Keimyung University, Daegu 41931; 2Department of Biochemistry, College of Medicine, Gachon University, Incheon 21999; 3Department of Immunology, School of Medicine and 4Institute of Medical Science, Keimyung University, Daegu 42601; 5Department of Surgery, Dongsan Medical Center, Keimyung University, Daegu 41931; 6Department of Pathology, School of Medicine, Keimyung University, Daegu 42601, Republic of Korea Received January 11, 2018; Accepted September 3, 2018 DOI: 10.3892/or.2018.6712 Abstract. Ceramide synthases (CerSs) synthesize various CERS5 mRNA levels in The Cancer Genome Atlas Colon ceramides of different acyl chain lengths and serve important and Rectal Cancer dataset. Notably, CERS2 and CERS4, as roles in the proliferation and death of cancer cells by regu- well as CERS5 and CERS6 levels, were positively correlated lating sphingolipid metabolism-related signaling pathways. with each other in Korean patients with CRC. However, the The present study investigated the mRNA expression levels mRNA expression levels of these four CerS genes were not of various CerS genes using mRNA expression data from six associated with any clinicopathological characteristics in independent colorectal cancer (CRC) cohorts and a Korean Korean patients with CRC. Finally, overexpressing CERS2 or CRC dataset. Expression levels of CERS2, CERS5 and CERS6 inhibited the in vitro viability of various CRC cells.
    [Show full text]
  • Download Article (PDF)
    Article in press - uncorrected proof BioMol Concepts, Vol. 1 (2010), pp. 411–422 • Copyright ᮊ by Walter de Gruyter • Berlin • New York. DOI 10.1515/BMC.2010.028 Review Ceramide synthases in mammalians, worms, and insects: emerging schemes Andre´ Voelzmann and Reinhard Bauer* plasmic reticulum (ER) by condensing activated palmitate LIMES Institute, Program Unit Development and Genetics, (palmitoyl-CoA) with L-serine through the activity of serine Laboratory for Molecular Developmental Biology, palmitoyl transferase (SPT); (3). The formed intermediate University of Bonn, Carl-Troll-Str. 31, D-53115 Bonn, 3-ketosphinganine is then turned to sphinganine by the 3- Germany ketosphinganine reductase (4). CerS now catalyze the CoA- dependent dihydroceramide synthesis. In this step, CoA * Corresponding author activated fatty acids are used for aminoacylation of sphin- e-mail: [email protected] ganine carbon-2 (Figure 1). The generated dihydroceramide is further converted to ceramide by dihydroceramide desa- turase. Initially, the molecular identity of enzymes and bio- Abstract chemical pathways of the de novo biosynthetic pathway have The ceramide synthase (CerS) gene family comprises a been identified and characterized, especially in mammalian group of highly conserved transmembrane proteins, which cells and the budding yeast Saccharomyces cerevisiae (5–7). are found in all studied eukaryotes. The key feature of the Thus, it became evident that these lipids and enzymes were CerS proteins is their role in ceramide synthase activity. conserved across species and phyla. Therefore, their original name ‘longevity assurance gene (Lass) homologs’, after the founding member, the yeast lon- gevity assurance gene lag1, was altered to ‘CerS’. All CerS Identification of ceramide synthases have high sequence similarity in a domain called LAG1 motif and a subset of CerS proteins is predicted to contain a Although CerS activity was detected previously in 1970 (8), Homeobox (Hox) domain.
    [Show full text]
  • Supporting Information
    Supporting Information Jensen et al. 10.1073/pnas.1316700111 SI Materials and Methods Western Blot Analysis. For all Western blot analyses, proteins were Cloning of Bcl2L13 and Mutagenesis of Bcl2L13. Full-length Bcl2-like separated by 4–12% SDS/PAGE (Life Technologies), transferred 13 (Bcl2L13) was cloned into pCDNA3-V5-His (Invitrogen) to Hybond PVDF membranes (Amersham), blocked with 5% using unique EcoRV/XhoI restriction sites and into the CSII- (wt/vol) milk in PBS with 0.1% Tween 20 (PBS/Tween) for 1 h, CMV-MCS-IRES2-Venus lentiviral vector via NheI/AgeI re- washed with PBS/Tween, and incubated with the following an- striction sites. To delete the BHNo domain (amino acids 207–459, tibodies: anti-actin (Santa Cruz), anti-Bax (Millipore), anti- – base pairs 621–1377) of Bcl2L13, mutagenesis PCR was em- Bcl2L13 (Proteintech), anti cleaved caspase-3 (Cell Signaling), – – ployed using primers ATACTGCTGTTTGGAGGGGCTGCT- anti cleaved caspase-7 (Cell Signaling), anti cleaved caspase-9 GCTGTTGCC and AAGACTAAACACACAGTGCCCCAGC- (Cell Signaling), anti-COXIV (Cell Signaling), anti-COX17 (Santa Cruz), anti–Bcl-2 (Millipore), anti–Bcl-x (Cell Signaling), CACCTTG that amplified a mutant Bcl2L13 lacking the BHNo L anti-Bak (Cell Signaling), anti-Hsp70 (BD Pharmingen), anti- domain (ΔBHNo). The mutant PCR product was ligated back LASS2 (CerS2; Abnova), anti-LASS6 (CerS6; Abnova), anti- together and was transformed. FLAG (Sigma), anti-HA (Santa Cruz), and anti-V5 (Invitrogen). Lentiviral Production and Infection. 293FT cells were plated in a The blots were washed with PBS/Tween and subsequently were 10-cm dish at 3 × 106 cells per plate. After 24 h, cells were trans- incubated with goat anti-rabbit IgG or with goat anti-mouse fected with 3 μg of target lentiviral construct, 1.25 μg of pMD2.G antibodies (Santa Cruz) in 5% (wt/vol) milk PBS/Tween.
    [Show full text]
  • Biomolecules
    biomolecules Article Ceramide Synthase 6: Comparative Analysis, Phylogeny and Evolution Roger S. Holmes 1,2,*, Keri A. Barron 2 and Natalia I. Krupenko 2,* 1 Griffith Research Institute for Drug Discovery and School of Environment and Science, Griffith University, Nathan, QLD 4111, Australia 2 Department of Nutrition, UNC-Chapel Hill, UNC Nutrition Research Institute, Kannapolis, NC 28081, USA; [email protected] * Correspondence: r.holmes@griffith.edu.au (R.S.H.); [email protected] (N.I.K.); Tel.: +61-4-1058-3348 (R.S.H.); +1-704-250-5054 (N.I.K.) Received: 30 August 2018; Accepted: 1 October 2018; Published: 8 October 2018 Abstract: Ceramide synthase 6 (CerS6, also known as LASS6) is one of the six members of ceramide synthase gene family in humans. Comparisons of CerS6 amino acid sequences and structures as well as of CerS6 gene structures/locations were conducted using data from several vertebrate genome projects. A specific role for the CerS6 gene and protein has been identified as the endoplasmic reticulum C14- and C16-ceramide synthase. Mammalian CerS6 proteins share 90–100% similarity among different species, but are only 22–63% similar to other CerS family members, suggesting that CerS6 is a distinct gene family. Sequence alignments, predicted transmembrane, lumenal and cytoplasmic segments and N-glycosylation sites were also investigated, resulting in identification of the key conserved residues, including the active site as well as C-terminus acidic and serine residues. Mammalian CerS6 genes contain ten exons, are primarily located on the positive strands and transcribed as two major isoforms. The human CERS6 gene promoter harbors a large CpG island (94 CpGs) and multiple transcription factor binding sites (TFBS), which support precise transcriptional regulation and signaling functions.
    [Show full text]
  • Noncoding Variations in the Gene Encoding Ceramide Synthase 6 Are Associated with Type 2 Diabetes in a Large Indigenous Australian Pedigree
    Twin Research and Human Genetics (2019), 22,79–87 doi:10.1017/thg.2019.13 Article Noncoding Variations in the Gene Encoding Ceramide Synthase 6 are Associated with Type 2 Diabetes in a Large Indigenous Australian Pedigree David A. Good1, David L. Duffy2, Manuela Good1, Cheng Xia Guo1, Frances Busfield1, Anthony Shaw1 and Joanne T. E. Shaw1,2,* 1Diabetes Research Laboratories, School of Clinical Medicine Prince Charles Hospital Northside Clinical Unit, Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia and 2QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia Abstract Type 2 diabetes (T2D) is a chronic disease that disproportionately affects Indigenous Australians. We have previously reported the localization of a novel T2D locus by linkage analysis to chromosome 2q24 in a large admixed Indigenous Australian pedigree (Busfield et al. (2002). American Journal of Human Genetics, 70, 349–357). Here we describe fine mapping of this region in this pedigree, with the identification of SNPs showing strong association with T2D: rs3845724 (diabetes p = 7 × 10−4), rs4668106 (diabetes p = 9 × 10−4) and rs529002 (plasma glucose p = 3 × 10−4). These associations were successfully replicated in an independent collection of Indigenous Australian T2D cases and controls. These SNPs all lie within the gene encoding ceramide synthase 6 (CERS6) and thus may regulate ceramide synthesis. Keywords: chronic disease; diabetes; genetic association; indigenous health (Received 20 January 2019; accepted 11 March 2019) Type 2 diabetes (T2D) is characterized by hyperglycemia due to of T2D and associated metabolic disturbances in Indigenous impaired insulin secretion, insulin resistance in muscle and Australians are of substantial importance for study as they are nonsuppressible hepatic glucose production (DeFronzo, 1988).
    [Show full text]
  • Table S1. 103 Ferroptosis-Related Genes Retrieved from the Genecards
    Table S1. 103 ferroptosis-related genes retrieved from the GeneCards. Gene Symbol Description Category GPX4 Glutathione Peroxidase 4 Protein Coding AIFM2 Apoptosis Inducing Factor Mitochondria Associated 2 Protein Coding TP53 Tumor Protein P53 Protein Coding ACSL4 Acyl-CoA Synthetase Long Chain Family Member 4 Protein Coding SLC7A11 Solute Carrier Family 7 Member 11 Protein Coding VDAC2 Voltage Dependent Anion Channel 2 Protein Coding VDAC3 Voltage Dependent Anion Channel 3 Protein Coding ATG5 Autophagy Related 5 Protein Coding ATG7 Autophagy Related 7 Protein Coding NCOA4 Nuclear Receptor Coactivator 4 Protein Coding HMOX1 Heme Oxygenase 1 Protein Coding SLC3A2 Solute Carrier Family 3 Member 2 Protein Coding ALOX15 Arachidonate 15-Lipoxygenase Protein Coding BECN1 Beclin 1 Protein Coding PRKAA1 Protein Kinase AMP-Activated Catalytic Subunit Alpha 1 Protein Coding SAT1 Spermidine/Spermine N1-Acetyltransferase 1 Protein Coding NF2 Neurofibromin 2 Protein Coding YAP1 Yes1 Associated Transcriptional Regulator Protein Coding FTH1 Ferritin Heavy Chain 1 Protein Coding TF Transferrin Protein Coding TFRC Transferrin Receptor Protein Coding FTL Ferritin Light Chain Protein Coding CYBB Cytochrome B-245 Beta Chain Protein Coding GSS Glutathione Synthetase Protein Coding CP Ceruloplasmin Protein Coding PRNP Prion Protein Protein Coding SLC11A2 Solute Carrier Family 11 Member 2 Protein Coding SLC40A1 Solute Carrier Family 40 Member 1 Protein Coding STEAP3 STEAP3 Metalloreductase Protein Coding ACSL1 Acyl-CoA Synthetase Long Chain Family Member 1 Protein
    [Show full text]
  • Role of Bcl-Rambo in Apoptosis and Mitophagy
    Cell S f ign l o a a li n n r g u Meng/Liwei Zhang/Hongzhi Wang/Haiming Dai, J o J Journal of Cell Signaling Cell Signal 2018, 3:3 ISSN: 2576-1471 DOI: 10.4172/2576-1471.1000192 Commentary Open Access Role of Bcl-rambo in Apoptosis and Mitophagy Fei Meng1,2,#, Liwei Zhang1,#, Hongzhi Wang1,2 and Haiming Dai1,2* 1Hefei Cancer Hospital, Chinese Academy of Sciences, Hefei, 230031, China 2Anhui Province Key Laboratory of Medical Physics and Technology, Center of Medical Physics and Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, China #Co-first authors *Corresponding author: Haiming Dai, Center of Medical Physics and Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, China, Tel: +86-551-62727063; E-mail: [email protected] Received date: September 13, 2018; Accepted date: September 21, 2018; Published date: October 1, 2018 Copyright: ©2018 Meng F, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Short Communication mitochondrial apoptotic pathway were added [10,11]. The pro- apoptotic function of Bcl-rambo is mediated by the BHNo domain and Bcl-rambo, also known as Bcl-2 Like protein 13 (Bcl-2-L13), with TM domain rather than the BH domains. While Bcl-2 family proteins homology to Bcl-2 protein and might contain all of the four conserved generally display anti-apoptotic or pro-apoptotic functions through Bcl-2 homology (BH) domains, BH1, BH2, BH3 and BH4 (Figure 1) forming hetero- or homodimers [12,13], however, Bcl-rambo does not [1,2].
    [Show full text]
  • Original Article Ceramide Synthase 6 Predicts Poor Prognosis and Activates the AKT/Mtor/4EBP1 Pathway in High-Grade Serous Ovarian Cancer
    Am J Transl Res 2020;12(9):5924-5939 www.ajtr.org /ISSN:1943-8141/AJTR0111977 Original Article Ceramide synthase 6 predicts poor prognosis and activates the AKT/mTOR/4EBP1 pathway in high-grade serous ovarian cancer Yinong Shi1*, Chen Zhou2*, Huan Lu1, Xiaoxiao Cui1, Jun Li3, Shuheng Jiang3, Hao Zhang4, Rong Zhang1 1Fengxian District Center Hospital Graduate Student Training Base, Jinzhou Medical University, Shanghai 201499, China; 2Department of Obstetrics and Gynecology, The Affiliated Changzhou No. 2 People’s Hospital of Nanjing Medical University, Changzhou 213000, Jiangsu, China; 3State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200240, China; 4Department of Obstetrics and Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai 200011, China. *Equal contributors. Received April 5, 2020; Accepted July 26, 2020; Epub September 15, 2020; Published September 30, 2020 Abstract: Objective: Ovarian cancer is one of the most common gynecological malignancies worldwide, and its mor- tality rate ranks first among gynecologic cancers. Ceramide synthases are closely related to cancer development. In this study, we investigated the role of ceramide synthase 6 (CerS6) in the development of serous ovarian cancer. Methods: Expression of CerS6 in cancerous and healthy ovarian tissue was assessed by database analysis and im- munohistochemistry. The biological role of CerS6 in serous ovarian cancer cells was assessed by CerS6 knockdown followed by cell counting, colony formation, transwell migration, wound healing, and flow cytometry assays and mea- surement of tumor proliferation in nude mice. Signaling pathway components were analyzed by Western blotting. Gene enrichment was analyzed by GSEA and R, and RNA sequencing was used to compare the transcriptomes of serous ovarian cancer cells with and without CerS6 knockdown.
    [Show full text]
  • Ceramide Synthase 6: Comparative Analysis, Phylogeny and Evolution
    biomolecules Article Ceramide Synthase 6: Comparative Analysis, Phylogeny and Evolution Roger S. Holmes 1,2,*, Keri A. Barron 2 and Natalia I. Krupenko 2,* 1 Griffith Research Institute for Drug Discovery and School of Environment and Science, Griffith University, Nathan, QLD 4111, Australia 2 Department of Nutrition, UNC-Chapel Hill, UNC Nutrition Research Institute, Kannapolis, NC 28081, USA; [email protected] * Correspondence: r.holmes@griffith.edu.au (R.S.H.); [email protected] (N.I.K.); Tel.: +61-4-1058-3348 (R.S.H.); +1-704-250-5054 (N.I.K.) Received: 30 August 2018; Accepted: 1 October 2018; Published: 8 October 2018 Abstract: Ceramide synthase 6 (CerS6, also known as LASS6) is one of the six members of ceramide synthase gene family in humans. Comparisons of CerS6 amino acid sequences and structures as well as of CerS6 gene structures/locations were conducted using data from several vertebrate genome projects. A specific role for the CerS6 gene and protein has been identified as the endoplasmic reticulum C14- and C16-ceramide synthase. Mammalian CerS6 proteins share 90–100% similarity among different species, but are only 22–63% similar to other CerS family members, suggesting that CerS6 is a distinct gene family. Sequence alignments, predicted transmembrane, lumenal and cytoplasmic segments and N-glycosylation sites were also investigated, resulting in identification of the key conserved residues, including the active site as well as C-terminus acidic and serine residues. Mammalian CerS6 genes contain ten exons, are primarily located on the positive strands and transcribed as two major isoforms. The human CERS6 gene promoter harbors a large CpG island (94 CpGs) and multiple transcription factor binding sites (TFBS), which support precise transcriptional regulation and signaling functions.
    [Show full text]